Alon Kushnir, Founder and CEO: Headed for 9 years the regulatory QA and medical affairs at Deep Breeze Ltd and for 5 years at Circ MedTech, Mr. Kushnir has successfully led companies through FDA clearance, CE mark, KFDA, WHO prequalification and over 40 worldwide clinical studies in Europe, USA, Asia and Africa. He was also responsible and involved in the publication of more than 30 Peer reviewed papers and writing of over 10 patents. Mr. Kushnir was responsible for the global implementation of reimbursement programs, and for strategic design of medical business development programs. Mr. Kushnir was involved in contracting global strategic partners such as GE healthcare. Mr. Kushnir holds a B.Sc. in Life Science and Computer Science with honors from Bar Ilan University.
Igal Kushnir, MD, Founder and Medical Director: Holder of several medical device patents; invented a device in body thermoregulation for MTRE Advanced Technologies of which he was the founder and CEO for 5 years; invented a non-invasive functional imaging device of body organs such as the lungs and heart for Deep Breeze Ltd. of which he was the founder and CEO for 7 years; Dr. Kushnir has vast experience as a family physician specializing in Pediatrics and continues to work in a private clinical practice for the past 30 years; for 10 years held the position of chief physician and medical manager for a hospital for chronically ill patients; graduated cum laude from Tel Aviv University (Israel) and holds a Medical Degree specializing in Pediatrics.
Dr Ronit Bendori, Director in the Board: General Partner in Evergreen Ventures, since 2000. She focuses on Evergreen’s investments in the Healthcare sector. Prior to joining Evergreen, Ronit was the Vice President of Pharmos Ltd. (NASDAQ: PARS). Before Pharmos Ronit held senior positions as an expert in technology transfer at InterPharm Ltd. (Israel) and Ares-Serono (Switzerland). As one of its most experienced figures, Ronit is an active promoter of Israeli Healthcare industry. She was an adviser to former Chief Scientists at the Israeli Ministry of Industry and Trade on biotechnology issues. On behalf of the chief scientist she headed the Monitor Survey of the Israeli Biotechnology. Currently, she is a member of the advisory board of the Israeli Scientific American and on the advisory board of the Center for Women’s Health at Hadassah Hospital, Jerusalem. Ronit has taught Industrial Aspects of Biotechnology in various institutions, including the Weizmann Institute of Science. She has a Ph.D in molecular and cellular biology from the Weizmann Institute of Science. Ronit initiated and was responsible for Evergreen’s investment in Colbar, which was sold to Johnson & Johnson for $160M. Ronit was Colbar’s Chairperson and worked with the company from its early days till its acquisition. Ronit represents Evergreen on the boards of following medical device companies: Activiews,Corassist, Nephera, Niti, Notal and Peer Medical.